Back
Phathom Pharmaceuticals Stock Price Chart
![](/images/offers/ims/large/offer6.jpg)
Jeff Bezos's Plan Exposed
And for investors who get in now profits could be massive - click here for full story.
Buy
81
PHAT
Phathom Pharmaceuticals
Last Price:
10.36
Seasonality Move:
-8.21%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer5.jpg)
The Next Nvidia?
Go here now for this breaking story.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
Phathom Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.25 | Sell |
20-day SMA: | 10.69 | Sell |
50-day SMA: | 10.21 | Buy |
200-day SMA: | 9.32 | Buy |
8-day EMA: | 11 | Sell |
20-day EMA: | 10.82 | Sell |
50-day EMA: | 10.39 | Sell |
200-day EMA: | 9.96 | Buy |
Phathom Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 45.96 | Sell |
Chaikin Money Flow: | -349831 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Phathom Pharmaceuticals Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 10.35 while PHAT 8-day simple moving average is 11.25, which is a Sell signal.
- The stock price of PHAT is 10.35 while Phathom Pharmaceuticals 20-day SMA is 10.69, which makes it a Sell.
- Phathom Pharmaceuticals 50-day simple moving average is 10.21 while PHAT share price is 10.35, making it a Buy technically.
- PHAT stock price is 10.35 and Phathom Pharmaceuticals 200-day simple moving average is 9.32, creating a Buy signal.
PHAT Technical Analysis vs Fundamental Analysis
Buy
81
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a Buy
The current Phathom Pharmaceuticals [PHAT] share price is $10.35. The Score for PHAT is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
605.84M
Price in USD:
10.35
Share Volume:
493.6K
Phathom Pharmaceuticals 52-Week Range
52-Week High:
17.02
52-Week Low:
6.07
Buy
81
Phathom Pharmaceuticals (PHAT)
is a Buy
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?
The Phathom Pharmaceuticals stock price is 10.35 USD today. -
Will PHAT stock go up or go down?
Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Phathom Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is not overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
- Phathom Pharmaceuticals share price is 10.35 while PHAT 8-day exponential moving average is 11.00, which is a Sell signal.
- The stock price of PHAT is 10.35 while Phathom Pharmaceuticals 20-day EMA is 10.82, which makes it a Sell.
- Phathom Pharmaceuticals 50-day exponential moving average is 10.39 while PHAT share price is 10.35, making it a Sell technically.
- PHAT stock price is 10.35 and Phathom Pharmaceuticals 200-day simple moving average is 9.96, creating a Buy signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.34 per share, a decrease this year of $1.15 per share, and an increase next year of $1.18 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
- PHAT Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Phathom Pharmaceuticals is a Buy
- Phathom Pharmaceuticals Relative Strength Index (RSI) is 45.96, which suggest Phathom Pharmaceuticals is oversold
- The Bollinger Bands (25) for Phathom Pharmaceuticals is ( - ), which suggest Phathom Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Phathom Pharmaceuticals is ( - ), which suggest Phathom Pharmaceuticals is a Buy
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.